ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Dermatitis
Atopic Dermatitis
Food Hypersensitivity
Hidradenitis
Hidradenitis Suppurativa
Hypersensitivity
Pruritus

Eczema trials near Birmingham, AL, USA:

Locations recently updated

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 yea...

Enrolling
Eczema
Drug: Abrocitinib
Other: Placebo

Phase 3

Pfizer
Pfizer

Birmingham, Alabama, United States and 11 other locations

This study will assess the safety and tolerability of ARQ-151 cream 0.05% applied once a day for 4 weeks in infants with atopic dermatitis (eczema...

Enrolling
Atopic Dermatitis (Eczema)
Drug: ARQ-151 cream 0.05%

Phase 2

Arcutis Biotherapeutics
Arcutis Biotherapeutics

Birmingham, Alabama, United States and 12 other locations

The purpose of this study is to test if treatment with tralokinumab is safe and effectful to treat moderate-to-severe atopic hand eczema. Th...

Enrolling
Atopic Hand Eczema
Atopic Dermatitis
Drug: Placebo
Drug: Tralokinumab

Phase 3

LEO Pharma
LEO Pharma

Birmingham, Alabama, United States and 75 other locations

the treatment of adults with moderate to severe Atopic Dermatitis (Eczema). OpSCF will be compared to a placebo.OpSCF or placebo will be adm...

Active, not recruiting
Atopic Dermatitis
Biological: Placebo
Biological: OpSCF

Phase 2

Opsidio

Birmingham, Alabama, United States and 21 other locations

This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).

Enrolling
Atopic Dermatitis
Drug: Placebo
Drug: GHZ339

Phase 2

Novartis
Novartis

Birmingham, Alabama, United States and 16 other locations

The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...

Enrolling
Atopic Dermatitis
Drug: Lebrikizumab

Phase 4

Lilly
Lilly

Birmingham, Alabama, United States and 74 other locations

This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...

Active, not recruiting
Atopic Dermatitis
Drug: Placebo
Drug: ADX-914

Phase 2

Q32 Bio

Birmingham, Alabama, United States and 26 other locations

The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...

Enrolling
Eczema
Atopic Dermatitis
Drug: Placebo
Drug: Lebrikizumab

Phase 3

Lilly
Lilly

Birmingham, Alabama, United States and 86 other locations

This is a randomized, double-blind, placebo-controlled, multi-center, phase 2 study in patients with mild to moderate Atopic Dermatitis(AD), which co...

Enrolling
Atopic Dermatitis Eczema
Atopic Dermatitis
Other: Placebo
Drug: HY209GEL Active

Phase 2

Shaperon

Birmingham, Alabama, United States and 3 other locations

The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...

Active, not recruiting
Atopic Dermatitis
Drug: Dupilumab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Birmingham, Alabama, United States and 83 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems